Available from: Hanna Huber 1, Alina Schieren 2, Jens Juul Holst 3, Marie-Christine Simon 4 Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions a narrative review
From a discovery perspective, underexplored peptidereceptor systems offer several strategic advantages
It is an investigational drug that is still under phase 3 clinical trials, in which the researchers are evaluating the safety, dosing, efficacy, and long-term outcome in a larger population
May your BMI calculations stay accurate, your provider conversations stay productive, and your treatment outcomes stay exactly what the clinical trials promised.
Stress & emotional eating play a role Semaglutide primarily targets physical hunger, but different mechanisms drive emotional eating